| Parker At Somerset, Inc | |
| 15 Dellwood Lane, Somerset, New Jersey 08873 | |
| (732) 545-4200 | |
| Name | Parker At Somerset, Inc |
|---|---|
| Location | 15 Dellwood Lane, Somerset, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 79.5% |
| Medicare ID (CCN) | 315253 |
| Legal Business Name | Parker At Somerset Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1063819811 |
| Organization Name | PARKER AT SOMERSET INC |
| Address | 15 Dellwood Ln, Somerset, NJ 08873 |
| Phone Number | 732-545-4200 |
News Archive
In Colorado, New Hampshire, Florida and Kansas, hospitals are trying to be strategic to beat marketplace challenges.
Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.
Several states have sought to increase their tobacco taxes to fund health care programs and address budget deficits, but efforts to increase tobacco taxes in some cases have prevented the passage of health care proposals, the New York Times reports.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
This idea has drawn support for some GOP lawmakers seeking to get rid of the Independent Payment Advisory Board, but trial lawyers are already lining up against it. Meanwhile, a new Congressional Budget Office estimate indicates that because Medicare spending is slowing, the board may never actually have to spring into action.
› Verified 1 days ago
| NPI Number | 1639170657 |
| Organization Name | MARGARET MCLAUGHLIN MCCARRICK CARE CENTER, INC. |
| Doing Business As | MCCARRICK CARE CENTER |
| Address | 15 Dellwood Ln, Somerset, NJ 08873 |
| Phone Number | 732-545-4200 |
News Archive
In Colorado, New Hampshire, Florida and Kansas, hospitals are trying to be strategic to beat marketplace challenges.
Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.
Several states have sought to increase their tobacco taxes to fund health care programs and address budget deficits, but efforts to increase tobacco taxes in some cases have prevented the passage of health care proposals, the New York Times reports.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
This idea has drawn support for some GOP lawmakers seeking to get rid of the Independent Payment Advisory Board, but trial lawyers are already lining up against it. Meanwhile, a new Congressional Budget Office estimate indicates that because Medicare spending is slowing, the board may never actually have to spring into action.
› Verified 1 days ago
| NPI Number | 1699906909 |
| Organization Name | GENESIS REHAB SERVICES |
| Address | 15 Dellwood Ln, Somerset, NJ 08873 |
| Phone Number | 732-545-4200 |
News Archive
In Colorado, New Hampshire, Florida and Kansas, hospitals are trying to be strategic to beat marketplace challenges.
Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.
Several states have sought to increase their tobacco taxes to fund health care programs and address budget deficits, but efforts to increase tobacco taxes in some cases have prevented the passage of health care proposals, the New York Times reports.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
This idea has drawn support for some GOP lawmakers seeking to get rid of the Independent Payment Advisory Board, but trial lawyers are already lining up against it. Meanwhile, a new Congressional Budget Office estimate indicates that because Medicare spending is slowing, the board may never actually have to spring into action.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
In Colorado, New Hampshire, Florida and Kansas, hospitals are trying to be strategic to beat marketplace challenges.
Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.
Several states have sought to increase their tobacco taxes to fund health care programs and address budget deficits, but efforts to increase tobacco taxes in some cases have prevented the passage of health care proposals, the New York Times reports.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
This idea has drawn support for some GOP lawmakers seeking to get rid of the Independent Payment Advisory Board, but trial lawyers are already lining up against it. Meanwhile, a new Congressional Budget Office estimate indicates that because Medicare spending is slowing, the board may never actually have to spring into action.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 6.18 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.79 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.16 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.19 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.27 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.53 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 11.4 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.23 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.83 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.62 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.72 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.69 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.11 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.69 | 82.93 |
News Archive
In Colorado, New Hampshire, Florida and Kansas, hospitals are trying to be strategic to beat marketplace challenges.
Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering radiation doses three times faster than previous Elekta linear accelerators, Versa HD sets a higher benchmark for cancer treatment.
Several states have sought to increase their tobacco taxes to fund health care programs and address budget deficits, but efforts to increase tobacco taxes in some cases have prevented the passage of health care proposals, the New York Times reports.
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
This idea has drawn support for some GOP lawmakers seeking to get rid of the Independent Payment Advisory Board, but trial lawyers are already lining up against it. Meanwhile, a new Congressional Budget Office estimate indicates that because Medicare spending is slowing, the board may never actually have to spring into action.
› Verified 1 days ago
Complete Care At Willow Creek Location: 1165 Easton Ave, Somerset, New Jersey 08873 Phone: (732) 246-4100 | |
Regency Heritage Nursing And Rehabilitation Center Location: 380 Demott Lane, Somerset, New Jersey 08873 Phone: (732) 873-2000 | |
Somerset Woods Rehabilitation & Nursing Center Location: 780 Old New Brunswick Road, Somerset, New Jersey 08873 Phone: (732) 653-3000 |